The newly launched reusable Respimat inhalers can be used with up to six refill cartridges.
Women with chronic obstructive pulmonary disease are at greater risk of frequent and severe acute exacerbations than men
Good fitness levels in middle-aged people associated with lowering risks of chronic lung disease (COPD).
Would you recognise the predisposing factors that lead to an increased risk of hyperglycaemia with steroid therapy in people with diabetes?
Long-term use of high dose inhaled corticosteroids is associated with a “modest” increased risk of fractures in COPD patients
A large increase in CVD incidence takes place within 30 days of starting certain COPD therapies, research finds
Winter provides the perfect opportunity for pharmacy to ease the pressure on GP surgeries and A&E departments
Here we consider the role community pharmacy teams can play in the therapeutic management of COPD
What symptoms should pharmacists look for with COPD and when should suspected cases be referred to a GP?
Inhaled corticosteroids for COPD appear to double the risk of developing oral thrush compared to long-acting bronchodilators
Investment is being channelled into the technological advancement of the NHS and, in particular, apps for the management of chronic conditions
Pharmacy teams are being encouraged to support World COPD Day 2016 on Wednesday 16 November
This CPD module looks at how community pharmacists can support patients with chronic obstructive pulmonary disease
Adherence to maintenance treatments for COPD falls sharply in the first six months of treatment, researchers find
Even mild COPD exacerbations accelerate loss of lung function, researchers find
Patients with chronic obstructive pulmonary disease can experience generalised anxiety disorder
We consider the role of generic inhalers in asthma and COPD.
Two new inhaler devices have been launched for the treatment of COPD